Nanoleakage expression and microshear bond strength in the resin cement/dentin interface
Abstract
PURPOSE: The aim of this study was to evaluate dentin sealing ability and microshear bond strength of two different resin cements.
MATERIALS AND METHODS: Resin composite overlays (Estenia C&B) were fabricated and cemented to mid-dentin surfaces with either a self-adhesive resin cement (RelyX Unicem) or a resin cement with a self-etching primer (Panavia F2.0). After 24 h storage in water, the specimens were sectioned, placed into 50% (w/v) ammoniacal silver nitrate solution for 24 h, exposed to photodeveloping solution and observed using FE-SEM and EDS. Percentage distribution of metallic silver particles in the resin cement/dentin interface was calculated using digital image analysis software. In addition, small resin overlay cylinders were also bonded to dentin using either of the resin cements, and their bonding performance was evaluated with the microshear bond strength test. The statistical significance was defined as p ≤ 0.05.
RESULTS: No statistically significant difference was detected in the microshear bond strength between RelyX Unicem and Panavia F2.0 (24.9 ± 4.8 and 26.1 ± 5.3 MPa, respectively, p > 0.05). However, a significant difference was detected in silver particle penetration percentage between RelyX Unicem and Panavia F2.0 (7.4 ± 4.6 and 18.7 ± 8.7 MPa, respectively). The Kruskal-Wallis mean ranks for nanoleakage were 6.8 and 14.2, respectively (p < 0.05).
CONCLUSION: While the bond strengths of the two materials were comparable, the self-adhesive resin…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.